Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
31 studies found for:    " November 11, 2009":" December 11, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" November 11, 2009":" December 11, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † HIV Persistence and Viral Reservoirs
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir, tenofovir/emtricitabine
2 Unknown † HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Condition: HIV Infections
Interventions: Drug: Pioglitazone;   Other: Observation
3 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
4 Completed TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Condition: HIV Infections
Intervention: Drug: TMC278 (Rilpivirine) LA; Placebo
5 Completed Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
6 Terminated Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir
Condition: HIV Infections
Intervention: Drug: Kaletra
7 Unknown † Computerized Counseling to Promote Positive Prevention and HIV Health in Kenya
Condition: HIV Infections
Interventions: Other: CARE+ Kenya brief computer risk assessment session;   Other: CARE+ Kenya computer counseling session
8 Completed A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
Condition: HIV Infections
Interventions: Other: CARE+ Spanish computer counseling session;   Other: CARE+ Spanish brief computer risk assessment session
9 Completed
Has Results 		Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons
Conditions: HSV Infection;   HIV Infection
Interventions: Drug: acyclovir;   Drug: valacyclovir
10 Completed Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT
Condition: HIV Infection
Intervention:
11 Terminated Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections;   Hepatitis C Virus
Intervention:
12 Completed Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Condition: HIV Infections
Intervention:
13 Completed
Has Results 		Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: AERAS-402;   Biological: Placebo
14 Completed Cardiovascular Risk Evaluation and Antiretrovirals in HIV
Conditions: Cardiovascular Risk;   HIV Infections
Intervention:
15 Terminated Appropriate Timing of HAART in Co-infected HIV/TB Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: tenofovir, lamivudine, efavirenz
16 Completed Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
Condition: HIV Infection
Intervention:
17 Completed Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
Conditions: HIV Infection;   Rheumatic Disease;   Cancer;   Transplant;   Pediatrics
Intervention: Biological: Adjuvanted influenza A(H1N1) vaccines
18 Completed Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Conditions: HIV Infection;   Liver Failure;   Evidence of Liver Transplantation
Intervention: Drug: Raltegravir potassium
19 Completed A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 1;   Drug: GSK2248761 reference formulation;   Drug: GSK2248761 formulation 3;   Drug: GSK2248761 formulation 2 or 4
20 Completed Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers
Condition: Human Immunodeficiency Virus
Intervention: Drug: Raltegravir
To Top

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
† Indicates status has not been verified in more than two years